Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Bausch Health Companies Inc. (BHC)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
6.28+0.27 (+4.49%)
At close: 04:00PM EDT
6.37 +0.09 (+1.43%)
After hours: 07:25PM EDT
Advertisement

Bausch Health Companies Inc.

2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada

https://www.bauschhealth.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees19,600

Key Executives

NameTitlePayExercisedYear Born
Mr. Thomas J. AppioCEO & Director2.9MN/A1962
Mr. Thomas G. VadakethExec. VP & CFON/AN/A1963
Mr. Mirza DautbegovicSr. VP & COON/AN/AN/A
Mr. John S. BarresiSr. VP, Controller & Chief Accounting OfficerN/AN/A1973
Dr. Robert F. ButzVP of Medical & Scientific AffairsN/AN/AN/A
Mr. Arthur J. ShannonSr. VP and Head of Investor Relations & Global CommunicationsN/AN/AN/A
Ms. Seana CarsonExec. VP & Gen. CounselN/AN/A1972
Ms. Kathleen FitzpatrickSr. VP & Chief HR OfficerN/AN/AN/A
Dr. Tage Ramakrishna M.D.Chief Medical Officer and Pres of R&DN/AN/A1974
Mr. Jeff HartnessSr. VP of Market Access, Commercial Operations & Gov. AffairsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Corporate Governance

Bausch Health Companies Inc.’s ISS Governance QualityScore as of July 1, 2022 is 4. The pillar scores are Audit: 3; Board: 3; Shareholder Rights: 4; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement